Header Logo

Connection

Gary Holland to Antiprotozoal Agents

This is a "connection" page, showing publications Gary Holland has written about Antiprotozoal Agents.
Connection Strength

0.695
  1. Prospective, randomized trial of trimethoprim/sulfamethoxazole vs. pyrimethamine and sulfadiazine in the treatment of ocular toxoplasmosis: discussion. Ophthalmology. 2005 Nov; 112(11):1882-4.
    View in: PubMed
    Score: 0.237
  2. An update on current practices in the management of ocular toxoplasmosis. Am J Ophthalmol. 2002 Jul; 134(1):102-14.
    View in: PubMed
    Score: 0.188
  3. Ocular toxoplasmosis: new directions for clinical investigation. Ocul Immunol Inflamm. 2000 Mar; 8(1):1-7.
    View in: PubMed
    Score: 0.160
  4. Ocular toxoplasmosis: a global reassessment. Part II: disease manifestations and management. Am J Ophthalmol. 2004 Jan; 137(1):1-17.
    View in: PubMed
    Score: 0.052
  5. Ocular Involvement Following an Epidemic of Toxoplasma gondii Infection in Santa Isabel do Iva?, Brazil. Am J Ophthalmol. 2015 Jun; 159(6):1013-1021.e3.
    View in: PubMed
    Score: 0.028
  6. Intraocular inflammation associated with ocular toxoplasmosis: relationships at initial examination. Am J Ophthalmol. 2008 Dec; 146(6):856-65.e2.
    View in: PubMed
    Score: 0.018
  7. Ocular toxoplasmosis misdiagnosed as cytomegalovirus retinopathy in immunocompromised patients. Ophthalmology. 1994 Mar; 101(3):499-507.
    View in: PubMed
    Score: 0.007
  8. Current practices in the management of ocular toxoplasmosis. Am J Ophthalmol. 1991 May 15; 111(5):601-10.
    View in: PubMed
    Score: 0.005
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.